<DOC>
	<DOCNO>NCT01145599</DOCNO>
	<brief_summary>The purpose study identify eye show worsen disease progression ( progressor phenotype ) .</brief_summary>
	<brief_title>Identifying Progression Retinal Disease Eyes With NPDR Diabetes Type 2 Using Non-invasive Procedures</brief_title>
	<detailed_description>To identify `` progressors '' retinal vascular disease central retinal edema type 2 diabetic patient early NPDR , base retinal disease progression baseline 12-month visit , assess follow biomarkers : - Microaneurysms turnover ( MA formation rate equal 2 , i.e . number new MA baseline 12-month visit ) compute color fundus photograph use RetmarkerDR software ; - Retinal thickness increase eye retinal thickening ( Increase retinal thickness normal range ) central subfield , inner ring and/or outer ring Constantly Present , Present Absent ( measure OCT consider macula thickness normative data .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Diabetes type 2 accord 1985 WHO criteria 2 . Age 35 75 year 3 . Mild nonproliferative diabetic retinopathy ( level 20 35 , base ETDRS criterion ) 7 field color fundus photography 4 . Presence least 1 microaneurysm central 3000 micr . diameter area ( correspond 2 DA ) Field 2 5 . Best Corrected Visual Acuity &gt; = 75 letter ( &gt; = 20 /32 ) 6 . Refraction spherical equivalent le 5 Dp 7 . Informed consent 1 . Cataract eye disease may interfere fundus examination 2 . Glaucoma 3 . Any eye surgery within period 6months 4 . Other retinal vascular disease 5 . Previous laser therapy 6 . Dilatation pupil &lt; 5 mm</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>